Stock market today: Nasdaq closes above 23,000 for first time as tech rebounds
LONDON - Genus PLC reported a 24% increase in adjusted profit before tax to £74.3 million for the fiscal year ended June 30, 2025, according to a preliminary results statement released Thursday.
The animal genetics company saw its adjusted operating profit including joint ventures rise 19% to £93.1 million in actual currency, driven by growth across its porcine and bovine business segments.
Revenue edged up 1% to £672.8 million, representing a 5% increase in constant currency terms. The company’s statutory profit before tax reached £28.5 million, up from £5.5 million in the previous year.
Genus generated record free cash flow of £40.9 million, compared to a £3.2 million outflow in the prior year. Cash generated by operations nearly doubled to £106.2 million, with a conversion rate of 114%.
The company’s PIC (Porcine Improvement Company) division reported continued strong trading across the Americas and Asia in the second half, with adjusted operating profit including joint ventures increasing 16% for the year in constant currency terms.
The ABS (Animal Breeding Services) bovine division saw substantial improvement in adjusted operating profit to £19.5 million, up from £14.0 million in the previous year, driven by the company’s Value Acceleration Programme initiatives.
In April 2025, Genus achieved FDA approval for its PRRS-resistant pig gene edit for use in the U.S. food supply chain, marking a significant milestone for the company.
The board maintained the final dividend at 21.7 pence per share, keeping the total dividend unchanged at 32.0 pence.
In a separate announcement Thursday, Genus revealed it has signed agreements with Beijing Capital Agribusiness to accelerate the formation of a Chinese joint venture, with Genus receiving a gross cash payment of $160 million upon completion.
For fiscal year 2026, the company expects "significant growth in Group adjusted profit before tax in constant currency," according to the statement.
Net debt decreased by £20.5 million to £228.2 million, with a year-end net debt to adjusted EBITDA ratio of 1.5x, down from 2.0x in the previous year.
This article is based on a press release statement from Genus PLC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.